ATE272608T1 - Bicyclo (2.2.1) heptane und verwandte verbindungen - Google Patents

Bicyclo (2.2.1) heptane und verwandte verbindungen

Info

Publication number: ATE272608T1
Authority: AT; Austria
Prior art keywords: heptanes; bicyclo; related compounds; compounds
Prior art date: 1998-03-17

Application number

AT99905122T

Other languages

English (en)

Inventor

Bertrand Leo Chenard

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-17

Filing date

1999-03-04

Publication date

2004-08-15

1999-03-04 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-08-15 Application granted granted Critical

2004-08-15 Publication of ATE272608T1 publication Critical patent/ATE272608T1/de

Links

IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 title 2
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT99905122T 1998-03-17 1999-03-04 Bicyclo (2.2.1) heptane und verwandte verbindungen ATE272608T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7834698P	1998-03-17	1998-03-17
PCT/IB1999/000376 WO1999047490A1 (en)	1998-03-17	1999-03-04	Bicyclo[2.2.1]heptanes and related compounds

Publications (1)

Publication Number	Publication Date
ATE272608T1 true ATE272608T1 (de)	2004-08-15

Family

ID=22143450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99905122T ATE272608T1 (de)	1998-03-17	1999-03-04	Bicyclo (2.2.1) heptane und verwandte verbindungen

Country Status (40)

Country	Link
US (1)	US6136861A (de)
EP (1)	EP1064256B1 (de)
JP (1)	JP3665567B2 (de)
KR (1)	KR100372981B1 (de)
CN (1)	CN1231461C (de)
AP (1)	AP1116A (de)
AR (1)	AR017236A1 (de)
AT (1)	ATE272608T1 (de)
AU (1)	AU753422B2 (de)
BG (1)	BG104837A (de)
BR (1)	BR9908850A (de)
CA (1)	CA2321639C (de)
CO (1)	CO5090835A1 (de)
CZ (1)	CZ20003355A3 (de)
DE (1)	DE69919142T2 (de)
DZ (1)	DZ2745A1 (de)
EA (1)	EA003946B1 (de)
ES (1)	ES2224604T3 (de)
GT (1)	GT199900040A (de)
HR (1)	HRP20000611A2 (de)
HU (1)	HUP0101031A3 (de)
ID (1)	ID25651A (de)
IL (1)	IL138342A0 (de)
IS (1)	IS5592A (de)
MA (1)	MA26614A1 (de)
MY (1)	MY121047A (de)
NO (1)	NO20004626L (de)
NZ (1)	NZ506227A (de)
OA (1)	OA11488A (de)
PE (1)	PE20000339A1 (de)
PL (1)	PL343278A1 (de)
PT (1)	PT1064256E (de)
SK (1)	SK13532000A3 (de)
TN (1)	TNSN99039A1 (de)
TR (1)	TR200002671T2 (de)
TW (1)	TW509667B (de)
UA (1)	UA53781C2 (de)
WO (1)	WO1999047490A1 (de)
YU (1)	YU53700A (de)
ZA (1)	ZA992094B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6555564B1 (en) *	1999-03-04	2003-04-29	The Board Of Trustees Of The University Of Illinois	Neuropharmacological treatments of sleep-related breathing disorders
US6313159B1 (en)	1999-08-20	2001-11-06	Guilford Pharmaceuticals Inc.	Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
UA73981C2 (en) *	2000-03-10	2005-10-17	Merck Patent Gmbh	(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JP2004532200A (ja) *	2001-03-15	2004-10-21	サエジスファーマシューティカルズ，インコーポレイテッド	全身性ストレスの後に認識機能を回復するための方法
US6689905B2 (en)	2001-06-29	2004-02-10	Wyeth	Stereoisomers of 3-aminotricyclo[2.2.1.0(2.6)]heptane-1,3-dicarboxylic acid
US6750364B2 (en)	2001-06-29	2004-06-15	Wyeth	Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport
US6689904B2 (en)	2001-06-29	2004-02-10	Wyeth	Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine
BR0212101A (pt)	2001-08-24	2004-08-24	Pharmacia & Up John Company	7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças
US7232798B2 (en) *	2001-11-13	2007-06-19	Tran Loi H	Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
FR2872045B1 (fr) *	2004-06-28	2006-09-29	Centre Nat Rech Scient Cnrse	Medicaments pour le traitement specifique de symptomes de la maladie de parkinson
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) *	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
JP5647519B2 (ja)	2007-09-13	2014-12-24	コンサートファーマシューティカルズインコーポレイテッド	重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成
TW200922566A (en)	2007-09-14	2009-06-01	Ortho Mcneil Janssen Pharm	1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
EA017648B1 (ru)	2007-09-14	2013-02-28	Орто-Макнейл-Янссен Фармасьютикалз, Инк.	1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
BRPI0816970A2 (pt) *	2007-09-14	2015-03-24	Ortho Mcneil Janssen Pharm	1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
CA2704436C (en) *	2007-11-14	2016-01-05	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5547194B2 (ja)	2008-09-02	2014-07-09	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
WO2010043396A1 (en)	2008-10-16	2010-04-22	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja)	2008-11-28	2015-03-25	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439015B (zh)	2009-05-12	2015-05-13	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
HRP20131122T1 (hr)	2009-05-12	2013-12-20	Janssen Pharmaceuticals, Inc.	Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
EP2661435B1 (de)	2010-11-08	2015-08-19	Janssen Pharmaceuticals, Inc.	1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja)	2010-11-08	2016-02-03	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド	１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
AR083845A1 (es) *	2010-11-18	2013-03-27	Lilly Co Eli	COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3
CN103209954B (zh)	2010-11-18	2015-09-02	伊莱利利公司	作为mGluR2/3拮抗剂的4-取代的-3-苄氧基-双环[3.1.0]己烷化合物
US9447025B2 (en)	2013-03-14	2016-09-20	Kalyra Pharmaceuticals, Inc.	Bicyclic analgesic compounds
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
US10189780B2 (en)	2013-12-12	2019-01-29	Zeno Royalties & Milestones, LLC	Bicyclic alkyl compounds and synthesis
PL3096790T3 (pl)	2014-01-21	2020-01-31	Janssen Pharmaceutica, N.V.	Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (de)	2014-01-21	2020-04-20	Janssen Pharmaceutica Nv	Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
CN106232567B (zh)	2014-03-07	2021-11-02	里科瑞尔姆Ip控股有限责任公司	螺桨烷衍生物及合成
CN106999451B (zh)	2014-09-17	2021-04-02	里科瑞尔姆Ip控股有限责任公司	双环化合物
US20190060257A1 (en) *	2016-03-16	2019-02-28	Zeno Royalties & Milestones, LLC	Analgesic compounds
EP3628043A4 (de)	2017-05-15	2021-04-28	Recurium IP Holdings, LLC	Analgetische verbindungen
MA53500A (fr)	2018-05-15	2021-08-18	Lloyd Hung Loi Tran	Composition d'agent thérapeutique et procédé d'utilisation, pour le traitement d'un trouble cognitif léger, de la dépression et de troubles psychologiques
KR102157141B1 (ko)	2018-11-27	2020-09-17	주식회사 파미니티	으아리 추출물을 유효 성분으로 포함하는 인지 기능 개선용 조성물
KR102172916B1 (ko)	2018-12-07	2020-11-02	주식회사 파미니티	실크 펩타이드 및 천연 추출물을 포함하는 인지 기능 개선용 조성물
US10844380B1 (en)	2019-06-17	2020-11-24	Biorchestra Co., Ltd.	Uses for prevention or treatment of brain diseases using microrna
US11198908B2 (en)	2019-06-17	2021-12-14	Biorchestra Co., Ltd.	Method for diagnosis of Alzheimer's disease using microRNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE199829T1 (de) *	1994-06-03	2001-04-15	Thejmde Trust	Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
PL182285B1 (pl) *	1994-08-12	2001-12-31	Lilly Co Eli	Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
GB9605429D0 (en) *	1995-11-16	1996-05-15	Lilly Co Eli	Excitatory amino acid receptor antagonists
WO1997017950A1 (en) *	1995-11-16	1997-05-22	Eli Lilly And Company	Shoulder prosthesis

1999
- 1999-03-04 IL IL13834299A patent/IL138342A0/xx unknown
- 1999-03-04 WO PCT/IB1999/000376 patent/WO1999047490A1/en not_active Ceased
- 1999-03-04 YU YU53700A patent/YU53700A/sh unknown
- 1999-03-04 PT PT99905122T patent/PT1064256E/pt unknown
- 1999-03-04 CZ CZ20003355A patent/CZ20003355A3/cs unknown
- 1999-03-04 EP EP99905122A patent/EP1064256B1/de not_active Expired - Lifetime
- 1999-03-04 AT AT99905122T patent/ATE272608T1/de not_active IP Right Cessation
- 1999-03-04 HR HR20000611A patent/HRP20000611A2/hr not_active Application Discontinuation
- 1999-03-04 HU HU0101031A patent/HUP0101031A3/hu unknown
- 1999-03-04 TR TR2000/02671T patent/TR200002671T2/xx unknown
- 1999-03-04 ES ES99905122T patent/ES2224604T3/es not_active Expired - Lifetime
- 1999-03-04 DE DE69919142T patent/DE69919142T2/de not_active Expired - Fee Related
- 1999-03-04 JP JP2000536687A patent/JP3665567B2/ja not_active Expired - Fee Related
- 1999-03-04 NZ NZ506227A patent/NZ506227A/xx unknown
- 1999-03-04 AU AU25409/99A patent/AU753422B2/en not_active Ceased
- 1999-03-04 EA EA200000842A patent/EA003946B1/ru not_active IP Right Cessation
- 1999-03-04 PL PL99343278A patent/PL343278A1/xx unknown
- 1999-03-04 ID IDW20001811A patent/ID25651A/id unknown
- 1999-03-04 KR KR10-2000-7010264A patent/KR100372981B1/ko not_active Expired - Fee Related
- 1999-03-04 BR BR9908850-9A patent/BR9908850A/pt not_active Application Discontinuation
- 1999-03-04 US US09/380,727 patent/US6136861A/en not_active Expired - Fee Related
- 1999-03-04 SK SK1353-2000A patent/SK13532000A3/sk unknown
- 1999-03-04 CN CNB998040401A patent/CN1231461C/zh not_active Expired - Fee Related
- 1999-03-04 CA CA002321639A patent/CA2321639C/en not_active Expired - Fee Related
- 1999-03-10 AP APAP/P/1999/001482A patent/AP1116A/en active
- 1999-03-12 TW TW088103874A patent/TW509667B/zh not_active IP Right Cessation
- 1999-03-12 PE PE1999000198A patent/PE20000339A1/es not_active Application Discontinuation
- 1999-03-15 AR ARP990101118A patent/AR017236A1/es unknown
- 1999-03-15 MY MYPI99000966A patent/MY121047A/en unknown
- 1999-03-16 DZ DZ990046A patent/DZ2745A1/xx active
- 1999-03-16 GT GT199900040A patent/GT199900040A/es unknown
- 1999-03-16 TN TNTNSN99039A patent/TNSN99039A1/fr unknown
- 1999-03-16 MA MA25498A patent/MA26614A1/fr unknown
- 1999-03-16 ZA ZA9902094A patent/ZA992094B/xx unknown
- 1999-03-17 CO CO99016567A patent/CO5090835A1/es unknown
- 1999-04-03 UA UA2000095327A patent/UA53781C2/uk unknown
2000
- 2000-08-18 IS IS5592A patent/IS5592A/is unknown
- 2000-09-15 NO NO20004626A patent/NO20004626L/no not_active Application Discontinuation
- 2000-09-18 OA OA1200000258A patent/OA11488A/en unknown
- 2000-10-11 BG BG104837A patent/BG104837A/bg unknown

Also Published As

Publication number	Publication date
SK13532000A3 (sk)	2002-07-02
ID25651A (id)	2000-10-19
NO20004626D0 (no)	2000-09-15
AP1116A (en)	2002-10-21
DE69919142T2 (de)	2005-01-20
GT199900040A (es)	2000-09-06
NO20004626L (no)	2000-11-13
WO1999047490A1 (en)	1999-09-23
JP3665567B2 (ja)	2005-06-29
CN1293655A (zh)	2001-05-02
YU53700A (sh)	2002-11-15
TW509667B (en)	2002-11-11
CN1231461C (zh)	2005-12-14
CA2321639A1 (en)	1999-09-23
DZ2745A1 (fr)	2003-09-08
EP1064256A1 (de)	2001-01-03
TNSN99039A1 (fr)	2005-11-10
EA003946B1 (ru)	2003-10-30
ES2224604T3 (es)	2005-03-01
EP1064256B1 (de)	2004-08-04
CZ20003355A3 (cs)	2002-05-15
US6136861A (en)	2000-10-24
TR200002671T2 (tr)	2000-12-21
PL343278A1 (en)	2001-08-13
EA200000842A1 (ru)	2001-04-23
MY121047A (en)	2005-12-30
BG104837A (bg)	2001-07-31
NZ506227A (en)	2003-06-30
PE20000339A1 (es)	2000-05-13
BR9908850A (pt)	2000-11-21
KR20010041951A (ko)	2001-05-25
ZA992094B (en)	2000-11-28
AR017236A1 (es)	2001-08-22
KR100372981B1 (ko)	2003-02-25
AU2540999A (en)	1999-10-11
DE69919142D1 (de)	2004-09-09
HUP0101031A2 (hu)	2001-08-28
AU753422B2 (en)	2002-10-17
CA2321639C (en)	2005-08-02
IS5592A (is)	2000-08-18
UA53781C2 (uk)	2003-02-17
IL138342A0 (en)	2001-10-31
AP9901482A0 (en)	1999-03-31
OA11488A (en)	2004-05-07
JP2002506847A (ja)	2002-03-05
HUP0101031A3 (en)	2003-05-28
MA26614A1 (fr)	2004-12-20
HRP20000611A2 (en)	2001-04-30
CO5090835A1 (es)	2001-10-30
PT1064256E (pt)	2004-10-29

Legal Events

Date

Code

Title

Description

2005-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1064256

Country of ref document: EP

2006-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69919142D1 (de)	2004-09-09	Bicyclo [2.2.1] heptane und verwandte verbindungen
ATE208762T1 (de)	2001-11-15	Parasitizide verbindungen
ATE429490T1 (de)	2009-05-15	Protease-varianten und verbindungen
DE69733649D1 (de)	2005-08-04	Calcylitische verbindungen
DE69616817D1 (de)	2001-12-13	Substituierte benzylaminopiperloin verbindungen
ATE212986T1 (de)	2002-02-15	Verbindungen die die retrovirale protease hemmen
ATE192157T1 (de)	2000-05-15	Therapeutisch verwendbare spiro-azabicyclische verbindungen
ATE206701T1 (de)	2001-10-15	Östrogene verbindungen
ATE193298T1 (de)	2000-06-15	Therapeutische verbindungen
ATE218536T1 (de)	2002-06-15	Entzündungshemmende verbindungen
SI1124961T1 (sl)	2007-06-30	Trombopoetinske spojine
DE69818643D1 (de)	2003-11-06	Pyrazine verbindungen
DE69329544D1 (de)	2000-11-16	HIV Protease hemmende Verbindungen
NO953638D0 (no)	1995-09-15	Gass-genererende kontrastmidler
ATE405580T1 (de)	2008-09-15	Antithrombotische verbindungen
ATE258921T1 (de)	2004-02-15	Aryl-annellierte azapolycyclische verbindungen
BR9605798A (pt)	1997-08-12	Fechadura de acionamento misto
DE69801556D1 (de)	2001-10-11	Spirocyclische Verbindungen
DE69535697D1 (de)	2008-03-20	Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel
DE59300245D1 (de)	1995-07-13	Schaumarme oberflächenaktive Verbindungen.
EP0645629A3 (de)	1995-11-29	Diagnostische Mittel für Osteoporose.
NZ505085A (en)	2002-10-25	Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
SI1064256T1 (en)	2004-10-31	Bicyclo (2.2.1) heptanes and related compounds
EP0800393A4 (de)	1998-05-06	4,4-(disubstituierte)cyclohexan-1-on monomere und verwandte verbindungen
DE69728220D1 (de)	2004-04-29	Antitumormittel mit silizium und stickstoff enthaltenden verbindungen als hauptbestandteil